Your 45-year-old female patient is in remission 1 year after completing her colon cancer treatment. She complains of persistent fatigue that affects her quality of life. Clinical history and laboratory studies tests show no major contributing factors other than her cancer treatment. Which of these interventions is most appropriate?

Your patient is undergoing evaluation following treatment with pelvic radiation therapy for prostate cancer. This patient is most likely at a slightly increased risk for which of these secondary cancers?

Your 60-year-old patient who is a breast cancer survivor is evaluated because of ongoing symptoms of fatigue. Which of these comorbidities is most likely to contribute to her fatigue?

Your 25-year-old female patient who is a Hodgkin disease survivor is undergoing evaluation because of ongoing chemotherapy-induced peripheral neuropathy (CIPN). Which of these is the most appropriate primary treatment of this patient's neuropathy?

Your 70-year-old male patient is undergoing treatment for colon cancer with oxaliplatin. Results of examination are consistent with peripheral neuropathy. Which of these best describes this patient's neuropathy course?